File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer

<p>BGA R script</p>

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Stéphane Fattori (15048281) (author)
Další autoři:	Aude Le Roy (16991145) (author), Jemila Houacine (16991148) (author), Lucie Robert (16991151) (author), Riad Abes (16991154) (author), Laurent Gorvel (15048296) (author), Samuel Granjeaud (15048278) (author), Marie-Sarah Rouvière (16991157) (author), Amira Ben Amara (16991160) (author), Nicolas Boucherit (16991163) (author), Carole Tarpin (16991166) (author), Jihane Pakradouni (16991169) (author), Emmanuelle Charafe-Jauffret (15090456) (author), Gilles Houvenaeghel (16991172) (author), Eric Lambaudie (16991175) (author), François Bertucci (10820542) (author), Philippe Rochigneux (15048269) (author), Anthony Gonçalves (15048284) (author), Arnaud Foussat (16991178) (author), Anne-Sophie Chrétien (16991181) (author), Daniel Olive (15048311) (author)
Vydáno:	2025
Témata:	Cancer Tumor Biology Therapeutic Research and Development Immuno-oncology Methods and Technology Breast Cancer Immunology Regulatory T cells Immunotherapy Combination immunotherapy Single Cell Technologies Translational Research Tumor Microenvironment
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Autor: Stéphane Fattori (15048281)
Vydáno: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Autor: Stéphane Fattori (15048281)
Vydáno: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Autor: Stéphane Fattori (15048281)
Vydáno: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Autor: Stéphane Fattori (15048281)
Vydáno: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Autor: Stéphane Fattori (15048281)
Vydáno: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Autor: Stéphane Fattori (15048281)
Vydáno: (2025)

Table S7 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Autor: Stéphane Fattori (15048281)
Vydáno: (2025)

Table S8 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Autor: Stéphane Fattori (15048281)
Vydáno: (2025)

Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4<sup>+</sup> T-cell Cluster That Correlates with PD-1 Blockade Efficacy
Autor: Hiroshi Kagamu (14961732)
Vydáno: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Autor: Hansol Lee (15054787)
Vydáno: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Autor: Hansol Lee (15054787)
Vydáno: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Autor: Hansol Lee (15054787)
Vydáno: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Autor: Hansol Lee (15054787)
Vydáno: (2025)

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Autor: Arianna Draghi (15126339)
Vydáno: (2025)

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Autor: Arianna Draghi (15126339)
Vydáno: (2025)

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Autor: Arianna Draghi (15126339)
Vydáno: (2025)

Supplementary Figure 1 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Autor: Francisco Exposito (16721403)
Vydáno: (2025)

Supplementary Figure 2 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Autor: Francisco Exposito (16721403)
Vydáno: (2025)

Supplementary Figure 3 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Autor: Francisco Exposito (16721403)
Vydáno: (2025)

Supplementary Figure 4 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Autor: Francisco Exposito (16721403)
Vydáno: (2025)

Supplementary Figure 5 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Autor: Francisco Exposito (16721403)
Vydáno: (2025)

Table 1_Integrating molecular targeting and immune modulation in triple-negative breast cancer: from mechanistic insights to therapeutic innovation.xlsx
Autor: Yueren Fan (22687577)
Vydáno: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
Autor: Andrew O. Yam (15293045)
Vydáno: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
Autor: Andrew O. Yam (15293045)
Vydáno: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
Autor: Andrew O. Yam (15293045)
Vydáno: (2025)

Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
Autor: Andrew O. Yam (15293045)
Vydáno: (2025)

Supplementary Table 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
Autor: Andrew O. Yam (15293045)
Vydáno: (2025)

Table S8 from Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
Autor: Sung-Eun Lee (14855067)
Vydáno: (2025)

Supplementary Table S2 from Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade
Autor: Dong-Chun Hong (16374308)
Vydáno: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Autor: Lavanya Sivapalan (15314248)
Vydáno: (2025)

Figure 1 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Figure 2 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Figure 3 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Figure 4 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Figure 5 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Figure 6 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Macros for image quantification from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Supplementary Data 2 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Supplementary Data 3 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Supplementary Data 4 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Autor: Massimiliano Mellone (14959419)
Vydáno: (2025)

Cannot write session to /tmp/vufind_sessions/sess_bsj10gb3mho8qfc1o0sr2tesn8